These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34506563)

  • 21. The usefulness of non-invasive liver stiffness measurements in predicting clinically significant portal hypertension in cirrhotic patients: Korean data.
    Hong WK; Kim MY; Baik SK; Shin SY; Kim JM; Kang YS; Lim YL; Kim YJ; Cho YZ; Hwang HW; Lee JH; Chae MH; Kim HA; Kang HW; Kwon SO
    Clin Mol Hepatol; 2013 Dec; 19(4):370-5. PubMed ID: 24459641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Wisteria floribunda agglutinin-positive Mac-2-binding protein as a diagnostic biomarker in liver cirrhosis: an updated meta-analysis.
    Feng S; Wang Z; Zhao Y; Tao C
    Sci Rep; 2020 Jun; 10(1):10582. PubMed ID: 32601332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis.
    Vizzutti F; Arena U; Romanelli RG; Rega L; Foschi M; Colagrande S; Petrarca A; Moscarella S; Belli G; Zignego AL; Marra F; Laffi G; Pinzani M
    Hepatology; 2007 May; 45(5):1290-7. PubMed ID: 17464971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How can we enhance the performance of liver stiffness measurement using FibroScan in diagnosing liver cirrhosis in patients with chronic hepatitis B?
    Kim SU; Kim DY; Park JY; Lee JH; Ahn SH; Kim JK; Paik YH; Lee KS; Chon CY; Choi EH; Song KJ; Park YN; Han KH
    J Clin Gastroenterol; 2010 Jan; 44(1):66-71. PubMed ID: 19609218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel scores combining AFP with non-invasive markers for prediction of liver fibrosis in chronic hepatitis C patients.
    Gamil M; Alboraie M; El-Sayed M; Elsharkawy A; Asem N; Elbaz T; Mohey M; Abbas B; Mehrez M; Esmat G
    J Med Virol; 2018 Jun; 90(6):1080-1086. PubMed ID: 29315641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Real time shear wave elastography in chronic liver diseases: accuracy for predicting liver fibrosis, in comparison with serum markers.
    Jeong JY; Kim TY; Sohn JH; Kim Y; Jeong WK; Oh YH; Yoo KS
    World J Gastroenterol; 2014 Oct; 20(38):13920-9. PubMed ID: 25320528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of transient elastography in assessing liver fibrosis in patients with autoimmune hepatitis.
    Xu Q; Sheng L; Bao H; Chen X; Guo C; Li H; Ma X; Qiu D; Hua J
    J Gastroenterol Hepatol; 2017 Mar; 32(3):639-644. PubMed ID: 27505153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimal liver stiffness measurement values for the diagnosis of significant fibrosis and cirrhosis in chronic liver disease in Singapore.
    Chang PE; Hartono JL; Ngai YL; Dan YY; Lim KB; Chow WC
    Singapore Med J; 2019 Oct; 60(10):532-537. PubMed ID: 30556091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus-coinfected patients with mild fibrosis in the short term.
    Macías J; Mancebo M; Márquez M; Merino D; Téllez F; Rivero A; von Wichmann MA; López-Cortés LF; Merchante N; Santos J; Raffo M; Pérez-Pérez M; Camacho Á; Iribarren JA; Pineda JA
    Hepatology; 2015 May; 61(5):1503-11. PubMed ID: 25545020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proposal of a predictive model for advanced fibrosis containing Wisteria floribunda agglutinin-positive Mac-2-binding protein in chronic hepatitis C.
    Nishikawa H; Takata R; Enomoto H; Yoh K; Kishino K; Shimono Y; Iwata Y; Hasegawa K; Nakano C; Nishimura T; Aizawa N; Sakai Y; Ikeda N; Takashima T; Ishii A; Iijima H; Nishiguchi S
    Hepatol Res; 2017 Mar; 47(3):E74-E84. PubMed ID: 27075409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accuracy of transient elastography in assessing liver fibrosis in chronic viral hepatitis: A multicentre, retrospective study.
    Seo YS; Kim MY; Kim SU; Hyun BS; Jang JY; Lee JW; Lee JI; Suh SJ; Park SY; Park H; Jung EU; Kim BS; Kim IH; Lee TH; Um SH; Han KH; Kim SG; Paik SK; Choi JY; Jeong SW; Jin YJ; Lee KS; Yim HJ; Tak WY; Hwang SG; Lee YJ; Lee CH; Kim DG; Kang YW; Kim YS;
    Liver Int; 2015 Oct; 35(10):2246-55. PubMed ID: 25682719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein evaluates liver function and predicts prognosis in liver cirrhosis.
    Xu WP; Wang ZR; Zou X; Zhao C; Wang R; Shi PM; Yuan ZL; Yang F; Zeng X; Wang PQ; Sultan S; Zhang Y; Xie WF
    J Dig Dis; 2018 Apr; 19(4):242-253. PubMed ID: 29607614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography.
    Masuzaki R; Tateishi R; Yoshida H; Goto E; Sato T; Ohki T; Imamura J; Goto T; Kanai F; Kato N; Ikeda H; Shiina S; Kawabe T; Omata M
    Hepatology; 2009 Jun; 49(6):1954-61. PubMed ID: 19434742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a non-invasive algorithm with transient elastography (Fibroscan) and serum test formula for advanced liver fibrosis in chronic hepatitis B.
    Wong GL; Wong VW; Choi PC; Chan AW; Chan HL
    Aliment Pharmacol Ther; 2010 May; 31(10):1095-103. PubMed ID: 20180785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein in Patients with Hepatitis C Virus-Related Compensated Liver Cirrhosis.
    Hasegawa K; Takata R; Nishikawa H; Enomoto H; Ishii A; Iwata Y; Miyamoto Y; Ishii N; Yuri Y; Nakano C; Nishimura T; Yoh K; Aizawa N; Sakai Y; Ikeda N; Takashima T; Iijima H; Nishiguchi S
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27626413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transient elastography for measurement of liver stiffness measurement can detect early significant hepatic fibrosis in Japanese patients with viral and nonviral liver diseases.
    Obara N; Ueno Y; Fukushima K; Nakagome Y; Kakazu E; Kimura O; Wakui Y; Kido O; Ninomiya M; Kogure T; Inoue J; Kondo Y; Shiina M; Iwasaki T; Yamamoto T; Shimosegawa T
    J Gastroenterol; 2008; 43(9):720-8. PubMed ID: 18807134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibroscan can avoid liver biopsy in Indian patients with chronic hepatitis B.
    Goyal R; Mallick SR; Mahanta M; Kedia S; Shalimar ; Dhingra R; Sharma H; Das P; Datta Gupta S; Panda S; Acharya SK
    J Gastroenterol Hepatol; 2013 Nov; 28(11):1738-45. PubMed ID: 23808910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How intrahepatic cholestasis affects liver stiffness in patients with chronic hepatitis B: a study of 1197 patients with liver biopsy.
    Guo H; Liao M; Jin J; Zeng J; Li S; Schroeder DR; Zheng J; Zheng R; Chen S
    Eur Radiol; 2020 Feb; 30(2):1096-1104. PubMed ID: 31673836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A proposed predictive model for advanced fibrosis in patients with chronic hepatitis B and its validation.
    Nishikawa H; Hasegawa K; Ishii A; Takata R; Enomoto H; Yoh K; Kishino K; Shimono Y; Iwata Y; Nakano C; Nishimura T; Aizawa N; Sakai Y; Ikeda N; Takashima T; Iijima H; Nishiguchi S
    Medicine (Baltimore); 2016 Aug; 95(35):e4679. PubMed ID: 27583895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver stiffness-based score in hepatoma risk assessment for chronic hepatitis C patients after successful antiviral therapy.
    Wang JH; Yen YH; Yao CC; Hung CH; Chen CH; Hu TH; Lee CM; Lu SN
    Liver Int; 2016 Dec; 36(12):1793-1799. PubMed ID: 27254286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.